Berrin Benli Yavuz1, Meryem Aktan2, Gul Kanyilmaz2, Lutfi Saltuk Demir3. 1. Department of Radiation Oncology, Meram Medical School, Necmettin Erbakan University, Konya, Turkey. berrinyavuz77@gmail.com. 2. Department of Radiation Oncology, Meram Medical School, Necmettin Erbakan University, Konya, Turkey. 3. Department of Public Health and Biostatistics, Meram Medical School, Necmettin Erbakan University, Konya, Turkey.
Abstract
PURPOSE: The aim of the present study is to investigate the effects of radiotherapy (RT) on quality of life (QoL) and influencing factors. METHODS: Data of 106 patients who completely filled out the three questionnaires were evaluated in this prospective study. Quality of life was evaluated with cancer-specific QLQ-C30 and colorectal cancer module QLQ-CR29 created by European Organization for Research and Treatment of Cancer (EORTC). All statistical analyses were done with SPSS version 22 software. A p level of < 0.05 was accepted as statistically significant. RESULTS: Median age was 61 (27-86). Of the patients, 77 (72.6%) were male and 29 (27.4%) were female. When QLQ-C30 questionnaires were evaluated, it was observed that physical, role, cognitive, and emotional function scores were impaired following RT, however returned to pre-RT levels on control. According to the results of QLQ-CR29 questionnaire, after RT, impairment was observed in urination frequency, urinary incontinence, stool frequency, dysuria, fecal incontinence, embarrassment, and sexual interest in male scales; however, they returned to pre-RT values on control. When evaluated with regard to age, financial difficulty, global health score, mucus in stool, dysuria, dyspareunia, and abdominal pain were observed to be poorer in the young; urination frequency and urinary incontinence were observed to be poorer in the elderly. CONCLUSION: Although both functional and symptom scales were shown to impair, most of them were detected to be temporal and patients could well tolerate radiotherapy. Additional assessment is required for evaluating the late effects of treatments on QoL.
PURPOSE: The aim of the present study is to investigate the effects of radiotherapy (RT) on quality of life (QoL) and influencing factors. METHODS: Data of 106 patients who completely filled out the three questionnaires were evaluated in this prospective study. Quality of life was evaluated with cancer-specific QLQ-C30 and colorectal cancer module QLQ-CR29 created by European Organization for Research and Treatment of Cancer (EORTC). All statistical analyses were done with SPSS version 22 software. A p level of < 0.05 was accepted as statistically significant. RESULTS: Median age was 61 (27-86). Of the patients, 77 (72.6%) were male and 29 (27.4%) were female. When QLQ-C30 questionnaires were evaluated, it was observed that physical, role, cognitive, and emotional function scores were impaired following RT, however returned to pre-RT levels on control. According to the results of QLQ-CR29 questionnaire, after RT, impairment was observed in urination frequency, urinary incontinence, stool frequency, dysuria, fecal incontinence, embarrassment, and sexual interest in male scales; however, they returned to pre-RT values on control. When evaluated with regard to age, financial difficulty, global health score, mucus in stool, dysuria, dyspareunia, and abdominal pain were observed to be poorer in the young; urination frequency and urinary incontinence were observed to be poorer in the elderly. CONCLUSION: Although both functional and symptom scales were shown to impair, most of them were detected to be temporal and patients could well tolerate radiotherapy. Additional assessment is required for evaluating the late effects of treatments on QoL.
Authors: Joseph M Herman; Amol K Narang; Kent A Griffith; Mark M Zalupski; Jennifer B Reese; Susan L Gearhart; Nolifer S Azad; June Chan; Leah Olsen; Jonathan E Efron; Theodore S Lawrence; Edgar Ben-Josef Journal: Int J Radiat Oncol Biol Phys Date: 2012-10-09 Impact factor: 7.038
Authors: Amy Downing; Adam W Glaser; Paul J Finan; Penny Wright; James D Thomas; Alexandra Gilbert; Jessica Corner; Mike Richards; Eva J A Morris; David Sebag-Montefiore Journal: Int J Radiat Oncol Biol Phys Date: 2018-12-13 Impact factor: 7.038
Authors: Alice M Couwenberg; Johannes P M Burbach; Wilhelmina M U van Grevenstein; Anke B Smits; Esther C J Consten; Anandi H W Schiphorst; Niels A T Wijffels; Joost T Heikens; Martijn P W Intven; Helena M Verkooijen Journal: Clin Colorectal Cancer Date: 2018-03-21 Impact factor: 4.481
Authors: Dan Asplund; Jane Heath; Elisabeth González; Jan Ekelund; Jacob Rosenberg; Eva Haglind; Eva Angenete Journal: Dan Med J Date: 2014-05 Impact factor: 1.240
Authors: R N Whistance; T Conroy; W Chie; A Costantini; O Sezer; M Koller; C D Johnson; S A Pilkington; J Arraras; E Ben-Josef; A M Pullyblank; P Fayers; J M Blazeby Journal: Eur J Cancer Date: 2009-09-16 Impact factor: 9.162
Authors: Jan Grosek; Jerica Novak; Katja Kitek; Alta Bajric; Ana Majdic; Jurij Ales Kosir; Ales Tomazic Journal: Radiol Oncol Date: 2019-03-14 Impact factor: 2.991